TuHURA Biosciences, Inc.
HURA· Nasdaq
HURATuHURA Biosciences, Inc.
Source filing unavailable
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2012 |
|---|---|---|
| Revenue | — | $0.00 |
| Net Income | $1.90M | -$3.25K |
| EPS Diluted | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
TuHURA Biosciences, Inc. · CIK 1498382 · Engraved from SEC EDGAR
